Response: As we noted in the CY 2026 OPPS/ASC proposed rule (90 FR 33774), while REHs may have some familiarity and experience with reporting eCQMs when formerly operating as a subsection (d) hospital or a CAH participating in the Medicare Promoting Interoperability Program, we recognize that technological, monetary, and staffing barriers may present challenges to eCQM adoption and use in some REHs
However, some peptides are on the WADA list, meaning they are prohibited for use by professional athletes
Your response can depend on your nutrient levels, metabolism, health history, and the type of injection used
We also include CMHCs in the first line that includes all providers
Seek medical attention If symptoms persist or worsen, a healthcare professional can assess potential nerve damage, tissue damage, or blood vessel injury
The kind of results that come from actual cellular repair, not masking